Skip Navigation



Brain Advance Access published online on November 25, 2003

Brain, doi:10.1093/brain/awh039
© 2003 by Guarantors of Brain
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
127/2/315    most recent
awh039v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Winter, C. D.
Right arrow Articles by Church, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, C. D.
Right arrow Articles by Church, M. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 The Guarantors of Brain

Article

Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury

Craig D. Winter 1, Ashley K Pringle 2*, Geraldine F. Clough 3, and Martin K. Church 3

1 Neurosurgical Department, Wessex Neurological Centre, Southampton, University Hospitals NHS Trust, Southampton, UK; Department of Clinical Neurosciences, University of Southampton Biomedical Sciences Building, Bassett Crescent East, Southampton, SO16 7PX, UK
2 Department of Clinical Neurosciences, University of Southampton Biomedical Sciences Building, Bassett Crescent East, Southampton, SO16 7PX, UK
3 Division of Infection, Inflammation and Repair, School of Medicine, University of Southampton, Southampton, UK

* Corresponding author. E-mail: akp1{at}soton.ac.uk.

Received 30 May 2003 ; revised 29 August 2003 ; accepted 9 September 2003

Abstract

Previous studies have suggested that an increased production of the pro-inflammatory cytokines interleukin-6 (IL-6) and interleukin-1{beta} (IL-1{beta}) can influence patient outcome following a severe head injury. However, these studies have relied upon measurements of cytokine levels in CSF or serum, rather than the brain parenchyma itself. Recently, a method of intracranial microdialysis has been developed which permits the efficient recovery of macromolecules from the parenchyma. We have used this technique to investigate whether there is a correlation between patient outcome and parenchymally derived cytokines. Fourteen patients who were admitted to the Wessex Neurological Centre with severe head injury were selected for the study. This group of patients consisted of seven males and seven females with an age range of 21-77 years. Patients were treated according to standard protocols including emergency craniotomy where necessary. Microdialysis probes were implanted into the frontal region contralateral to the site of the primary injury. Approximately 200 µl of dialysate was recovered every 8-12 h, and the concentrations of IL-6, IL-1{beta} and nerve growth factor (NGF) were determined by commercial enzyme-linked immunosorbent assays. Patients were assessed initially using the Glasgow coma score, and survivors were assessed after 6 months using the Glasgow outcome scale. Significantly (P = 0.04) higher levels of IL-6 were found in patients who survived compared with those who died. Also, there was a significant correlation between peak IL-6 levels and Glasgow outcome scores (r2 = 0.34, P = 0.03, n = 14). The levels of IL-1{beta} and NGF were similar in both groups of patients. From these data, we suggest that IL-6 is an endogenous neuroprotective cytokine produced in response to severe head trauma.

Keywords: microdialysis; cytokine, neuroinflammation; traumatic brain injury (TBI); interleukin-6
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Intensive Care MedHome page
H. J. Kadhim, J. Duchateau, and G. Sebire
Cytokines and Brain Injury: Invited Review
J Intensive Care Med, July 1, 2008; 23(4): 236 - 249.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.